The Falsified Medicines Directive is a key focus for the UK Competent Authority, the MHRA, and it is expected that as a UK Pharmaceutical wholesaler that you are aware of this emerging regulation.
The FMD comes into effect 09 Feb 2019, “Brexit” or not.
For more information around Falsified Medicines and the coding, see our blog from Sid Dajani HERE
Around the world there are other “track and trace” systems evolving, which potentially offer benefits to patients and product quality, but can increase workload for pharmacies and wholesalers, as well as putting their businesses at risk.
Inspectors from the MHRA (Medicines and Healthcare products Regulatory Agency) will expect your QMS to (Quality Management System) contain appropriate SOPs which cover the threat of falsified medicines, and cover checks and staff awareness of suspected falsified medicines, and all staff should be appropriately trained on falsified medicines.
The EU Directive 2011/62/EU of 8 June 2011, amending Directive 2001/83/EC, gives the following definition of “falsified medicines”:
Any medicinal product with a false representation of:
This definition does not include unintentional quality defects and is without prejudice to infringements of intellectual property rights.
To view examples of falsified medicines, please find the link to the World Health Organization.
So… does that make sense to me? In many cases, it doesn’t.
Falsified Medicines can now be;
1) Real product in false packaging – Real product from Turkey has been repackaged as Bulgarian, English or French stock, but where was it stored in between?
2) Stolen product diverted back into the supply chain – Goods which were stolen in Italy were then entered into the wholesale chain.
3) False product in real packaging – where goods are relabeled for PI or where they are destroyed you must destroy the packages and PILs to prevent them being used again.
4) Empty vials, refilled and introduced back into the supply chain – Italian Herceptin, which had been refilled after being stolen from hospital.
5) Diverted medicines which were dispensed, bought from the patients and then reintroduced – see this FBI case
This is not an exhaustive list!!
Which areas of your business are at highest risk for purchase or receipt of falsified products?
This list is an example, and not exhaustive.
Worried about the threat of falsified medicines?
Need training on falsified medicines?
Contact us for a no obligation chat and quote.
Welcome to a new Paradigm!
13 Mar 2017
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.